UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
VEGFR tyrosine kinase inhibitor II (VRI) induced vascular insufficiency in zebrafish as a model for studying vascular toxicity and vascular preservation Journal article
Shang Li, Yuan Ye Dang, Ginny Oi Lam Che, Yiu Wa Kwan, Shun Wan Chan, George Pak Heng Leung, Simon Ming Yuen Lee, Maggie Pui Man Hoi. VEGFR tyrosine kinase inhibitor II (VRI) induced vascular insufficiency in zebrafish as a model for studying vascular toxicity and vascular preservation[J]. Toxicology and Applied Pharmacology, 2014, 280(3), 408-420.
Authors:  Shang Li;  Yuan Ye Dang;  Ginny Oi Lam Che;  Yiu Wa Kwan;  Shun Wan Chan; et al.
Favorite | TC[WOS]:37 TC[Scopus]:37  IF:3.3/3.6 | Submit date:2018/11/06
Cardiovascular Protective Agents  Cardiovascular Toxicity  Vascular Insufficiency  Zebrafish Model  
Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo Journal article
Yi Zhang, Guang Hu, Shang Li, Zhen Hua Li, Che Oi Lam, Si-Jia Hong, iu‑Wa Kwan, Shun Wan Chan, George Pak-Heng Leung, Simon Ming-Yuen Lee. Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo[J]. Molecular Medicine Reports, 2012, 5(3), 805-811.
Authors:  Yi Zhang;  Guang Hu;  Shang Li;  Zhen Hua Li;  Che Oi Lam; et al.
Favorite | TC[WOS]:49 TC[Scopus]:55 | Submit date:2018/10/30
Angiogenesis  Astragaloside Iv  Human Umbilical Vein Endothelial Cell  Radix Astragali  Zebrafish